Erythropoiesis stimulating agents have limited therapeutic activity in transfusion-dependent patients with primary myelofibrosis regardless of serum erythropoietin level

Jocelin Huang, Ayalew Tefferi

Research output: Contribution to journalLetter

53 Scopus citations
Original languageEnglish (US)
Pages (from-to)154-155
Number of pages2
JournalEuropean Journal of Haematology
Volume83
Issue number2
DOIs
StatePublished - Aug 1 2009

ASJC Scopus subject areas

  • Hematology

Cite this